Inventor · disambiguated record
John Leonard
Also filed as: LEONARD JOHN · LEONARD JOHN P · LEONARD JOHN PATRICK
13 granted patents·12 pending applications·136 citations·filing 2000–2024
92Inventor score
Top patents by PatentIndex Score
25 records- 0192US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 0292US6338848B1Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseasesGENETICS INST·Filed 2000·Granted Jan 15, 2002·67 cites·5 claims
- 0390US9139580B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Granted Sep 22, 2015·14 cites·1 claims
- 0487US9126993B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Sep 8, 2015·9 cites·1 claims
- 0586US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 0686US8912177B2Method of treating polycystic kidney diseases with ceramide derivativesNATOLI THOMAS A·Filed 2008·Granted Dec 16, 2014·8 cites·13 claims
- 0784US6706264B1Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-yINST GENETICS LLC·Filed 2000·Granted Mar 16, 2004·16 cites·15 claims
- 0883US7534430B2Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseasesGENETICS INST LLC·Filed 2006·Granted May 19, 2009·4 cites·27 claims
- 0982US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
- 1076US8012475B2Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseasesGENETICS INST LLC·Filed 2009·Granted Sep 6, 2011·1 cites·12 claims
- 1176US6830751B1Use of IL-12 antagonists in the treatment of rheumatoid arthritisINST GENETICS LLC·Filed 2000·Granted Dec 14, 2004·6 cites·13 claims
- 1273US7138115B2Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseasesGENETICS INST LLC·Filed 2003·Granted Nov 21, 2006·4 cites·16 claims
- 1372US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 1469US2022409595A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2022·Application pending·0 cites
- 1568US2015216872A1Method of treating polycystic kidney diseases with ceramide derivativesGENZYME CORP·Filed 2014·Application pending·0 cites
- 1664US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 1757US2015210681A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Application pending·0 cites
- 1856US2023414648A1Compositions and Methods for Treatment of DM1 with SLUCAS9 and SACAS9VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1955US10220039B2Method of treating polycystic kidney diseases with ceramide derivativesGENZYME CORP·Filed 2017·Granted Mar 5, 2019·0 cites·10 claims
- 2055US2016361301A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Application pending·0 cites
- 2154US8231874B2Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseasesLEONARD JOHN·Filed 2011·Granted Jul 31, 2012·0 cites·15 claims
- 2254US2022186216A1Compositions and Methods for Treatment of Disorders Associated with Repetitive DNAVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2353US2016207933A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2015·Application pending·0 cites
- 2453US2013089515A1Use of IL-12 and IL-12 Antagonists in the Treatment of Autoimmune DiseasesLEONARD JOHN·Filed 2012·Application pending·0 cites
- 2551US2019046509A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Leonard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →